UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Identify which ETF dividends qualify for 199A and how to structure holdings to maximize the deduction within the rules.
20,727 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...
A big data-center lease helped Applied Digital stock soar, signaling strong demand for AI infrastructure. Learn what ...
Zero Network, a gasless Ethereum Layer 2 project, is closing its standalone chain after about 18 months of operation....
Wall Street’s bearish take on Plug Power stock has critics unsure. This article builds a practical bull case, showing...
Micron led gains in a tech-fueled rally as UBS boosted its price target on AI optimism. This article breaks down toda...
This deep dive breaks down NextPlat's Q1 2026 earnings, translating the numbers into practical takeaways for investor...
Imagine an AI that studies your crypto habits during idle moments and preps the next move you might take. This articl...
Investors cheered a decisive move higher as Okta unveiled AI-powered growth opportunities. The stock touched a new 52...
Bitcoin steadies ahead of a data-heavy week as macro signals, liquidity dynamics, and geopolitical headlines vie for ...
Anthropic is widening who can tap into Claude Mythos, just as IPO chatter heats up in the AI arena. This move could r...
A retiree couple taking in $9,500 per month sits on the edge of the 12%/22% federal tax brackets, where withdrawal ch...